Evonik Industries AG

XTRA:EVK Rapport sur les actions

Capitalisation boursière : €8.0b

Evonik Industries Résultats passés

Passé contrôle des critères 0/6

Les bénéfices de Evonik Industries ont diminué à un taux annuel moyen de -31.1%, tandis que le secteur Chemicals a vu ses bénéfices augmenter de en baisse à 4.4% par an. Les revenus ont augmenté de en baisse à un taux moyen de 0.8% par an. Le rendement des capitaux propres de Evonik Industries est 2% et ses marges nettes sont de 1.1%.

Informations clés

-31.14%

Taux de croissance des bénéfices

-31.11%

Taux de croissance du BPA

Chemicals Croissance de l'industrie12.41%
Taux de croissance des recettes-0.81%
Rendement des fonds propres2.05%
Marge nette1.14%
Prochaine mise à jour des résultats04 Aug 2026

Mises à jour récentes des performances passées

Article d’analyse • May 15

There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) Earnings

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

Recent updates

Article d’analyse • May 15

There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) Earnings

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...
Mise à jour du récit • May 03

EVK: Recent Upgrades And Dividend Support May Drive Medium Term Re Rating

Analysts have lifted their price targets on Evonik Industries by up to €2.40, reflecting updated views on slightly higher long term revenue growth and profit margins, alongside a modestly reduced discount rate and future P/E assumptions. Analyst Commentary Recent Street research on Evonik Industries has leaned clearly positive, with a cluster of upgrades and price target moves that underline improving confidence in the company’s long term fundamentals and valuation support.
Mise à jour du récit • Apr 19

EVK: Recent Upgrades And Margin Outlook Will Support Medium-Term Re Rating Potential

Analysts have revised the fair value estimate for Evonik Industries from €19.90 to €20.40, reflecting updated views on revenue growth, profit margins and the P/E multiple following a series of recent upgrades and price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of positive calls on Evonik Industries, with several bullish analysts adjusting their views and price targets in quick succession.
Mise à jour du récit • Apr 03

EVK: Recent Rating Shifts And Earnings Execution Will Drive Future Share Performance

Analysts have lifted the fair value estimate for Evonik Industries from about €14.60 to roughly €16.16, reflecting updated assumptions on growth and profitability in the wake of several recent upgrades and price target increases across the Street. Analyst Commentary Recent research on Evonik Industries shows a mix of optimism and caution, with several upgrades and price target lifts set against earlier downgrades that focused on execution risks and earnings visibility.
Mise à jour du récit • Mar 20

EVK: Margin Resilience And Lower Discount Rate Will Support Medium-Term Re Rating Potential

The analyst price target for Evonik Industries has been adjusted slightly higher to €19.90 from €19.77 as analysts factor in a modestly lower discount rate, slightly stronger margin assumptions, and a continued cautious view on revenue growth and future P/E. Analyst Commentary Recent Street research on Evonik Industries shows a mix of views, with some firms turning more cautious while others see improving risk reward.
Mise à jour du récit • Mar 06

EVK: Weaker Pricing Power Will Limit Earnings Delivery Despite Mixed Broker Views

Analysts have raised their fair value estimate for Evonik Industries from €11.60 to €12.20, citing updated assumptions on revenue growth, the discount rate and future P/E that broadly reflect recent mixed Street research, including higher price targets and rating changes. Analyst Commentary Recent Street research on Evonik Industries has been mixed, with some firms turning more constructive and others flagging ongoing execution and earnings risks.
Mise à jour du récit • Feb 20

EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.
Mise à jour du récit • Feb 06

EVK: Weaker Pricing Power Will Drive Lower Future Earnings Expectations

Analysts have trimmed their price expectations for Evonik Industries to around €11.60 per share, reflecting more cautious assumptions on revenue growth, profit margins and future P/E multiples following several recent downgrades and target cuts. Analyst Commentary Recent research points to a more cautious stance on Evonik Industries, with several bearish analysts trimming ratings and price targets and highlighting a mix of execution and earnings risks over the next few years.
Article d’analyse • Feb 06

Evonik Industries AG (ETR:EVK) Not Flying Under The Radar

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
Mise à jour du récit • Jan 23

EVK: Sector Caution And Margin Execution Will Shape Future Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from €15.68 to €14.60, reflecting a softer view on revenue growth and profit margins, alongside recent sector downgrades and lower price targets from several banks. Analyst Commentary Recent Street research on Evonik Industries has tilted more cautious, with several firms cutting ratings or price targets and focusing on execution risks around pricing, volumes and sector positioning.
Mise à jour du récit • Jan 08

EVK: Pricing And Volume Execution Risk Will Pressure Future Earnings

Analysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.
Mise à jour du récit • Dec 23

EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside Potential

Evonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.
Mise à jour du récit • Dec 09

EVK: Margin Resilience And Efficiency Measures Will Drive Future Upside Potential

The analyst price target for Evonik Industries has been revised modestly lower, from approximately EUR 16.14 to EUR 15.68. Analysts are factoring in softer revenue growth, slightly lower profit margins, and a more cautious sector stance, despite some institutions maintaining positive ratings.
Article d’analyse • Dec 04

Evonik Industries (ETR:EVK) Has A Somewhat Strained Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Mise à jour du récit • Nov 24

EVK: Sector Challenges Will Be Overcome By Advancing Delivery Platform Collaboration

Evonik Industries’ analyst price target has been reduced from approximately €18.12 to €16.14. Analysts point to a more cautious outlook on the company’s prospects, citing a series of sector downgrades and lowered revenue growth expectations.
Mise à jour du récit • Nov 06

EVK: Resilience And New Partnerships Will Drive Improved Revenue Outlook

Evonik Industries' analyst price target has been reduced slightly, with the updated consensus reflecting a minor decline of approximately EUR 0.25. Analysts cite ongoing cyclical and structural headwinds impacting earnings expectations.
Article d’analyse • Oct 30

Evonik Industries AG's (ETR:EVK) Earnings Haven't Escaped The Attention Of Investors

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...
Mise à jour du récit • Oct 23

Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic Moves

Evonik Industries' analyst price target has decreased modestly, dropping by approximately EUR 0.38 to EUR 18.37. Analysts cite increased caution due to reduced revenue growth expectations and ongoing earnings headwinds.
Mise à jour du récit • Oct 09

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

Evonik Industries’ analyst price target has been reduced from €19.88 to €18.75 as analysts cite increased downside risks to earnings from both cyclical and structural factors. Analyst Commentary Recent analyst activity reflects a mixed outlook on Evonik Industries, with both optimistic and cautious perspectives shaping the current consensus on the stock's valuation and prospects.
Mise à jour du récit • Sep 25

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

Evonik Industries' consensus price target has been reduced from €20.49 to €19.88 as analysts factor in increased downside risks to earnings, moderating growth expectations, persistent margin concerns, and industry headwinds, prompting greater near-term caution. Analyst Commentary Bearish analysts highlight increased downside risks to earnings estimates due to both cyclical and structural pressures facing the company.
Article d’analyse • Sep 13

Investors Met With Slowing Returns on Capital At Evonik Industries (ETR:EVK)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Mise à jour du récit • Sep 04

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

With both the Future P/E and Discount Rate remaining essentially stable, analysts have maintained Evonik Industries' fair value unchanged at €20.49. Valuation Changes Summary of Valuation Changes for Evonik Industries The Consensus Analyst Price Target remained effectively unchanged, at €20.49.
Article d’analyse • Aug 28

At €16.68, Is It Time To Put Evonik Industries AG (ETR:EVK) On Your Watch List?

Evonik Industries AG ( ETR:EVK ), is not the largest company out there, but it saw significant share price movement...
Article d’analyse • Jul 11

Investors Still Waiting For A Pull Back In Evonik Industries AG (ETR:EVK)

With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Germany, you could be...
Article d’analyse • Jun 26

Evonik Industries (ETR:EVK) Seems To Use Debt Quite Sensibly

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Article d’analyse • Jun 11

Evonik Industries' (ETR:EVK) Returns Have Hit A Wall

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
User avatar
Nouveau récit • Nov 25

Innovative Strategies And Cost Efficiency To Drive Exciting Growth In Emerging Sectors

Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins.

Ventilation des recettes et des dépenses

Comment Evonik Industries gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

XTRA:EVK Recettes, dépenses et bénéfices (EUR Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Mar 2613,7191572,160407
31 Dec 2514,0692652,207419
30 Sep 2514,265942,041436
30 Jun 2514,7074232,324437
31 Mar 2515,1382992,374442
31 Dec 2415,1572222,396447
30 Sep 2415,1632292,577424
30 Jun 2415,102-902,310434
31 Mar 2415,058-3562,301431
31 Dec 2315,267-4652,315433
30 Sep 2316,002-6042,371455
30 Jun 2317,109-2952,541455
31 Mar 2317,9952722,560461
31 Dec 2218,4885392,566460
30 Sep 2218,2389262,561471
30 Jun 2217,2319442,457474
31 Mar 2216,0958692,348472
31 Dec 2114,9557482,253464
30 Sep 2114,0787242,186449
30 Jun 2113,1246422,068435
31 Mar 2112,3145462,030428
31 Dec 2012,1994892,022433
30 Sep 2012,2706142,011430
30 Jun 2012,5856172,045433
31 Mar 2013,0656792,070430
31 Dec 1913,1087532,079428
30 Sep 1913,0845062,111437
30 Jun 1913,1996242,139435
31 Mar 1913,3066732,163443
31 Dec 1813,2676862,162437
30 Sep 1813,5808412,238446
30 Jun 1813,7897972,293457
31 Mar 1813,9947882,353467
31 Dec 1714,3837132,409476
30 Sep 1714,0157232,365462
30 Jun 1713,6237182,321455
31 Mar 1713,2626562,273445
31 Dec 1612,7327482,201438
30 Sep 1612,7257582,180448
30 Jun 1612,9267252,154441
31 Mar 1613,1889812,150436
31 Dec 1513,5071,0082,140434
30 Sep 1513,5351,0272,176416
30 Jun 1513,4131,0042,131416

Des revenus de qualité: EVK a un important ponctuel perte de €320.0M impactant ses 12 derniers mois de résultats financiers à 31st March, 2026.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de EVK sont inférieures à celles de l'année dernière EVK. (1.1%) sont inférieures à celles de l'année dernière (2%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de EVK ont diminué de 31.1% par an au cours des 5 dernières années.

Accélération de la croissance: EVK a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.

Bénéfices par rapport au secteur d'activité: EVK a enregistré une croissance négative de ses bénéfices ( -47.5% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Chemicals ( -13.5% ).

Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de EVK ( 2% ) est considéré comme faible.

Rendement des actifs

Rendement des capitaux employés

Découvrir des entreprises performantes dans le passé

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/26 20:50
Cours de l'action en fin de journée2026/05/26 00:00
Les revenus2026/03/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Evonik Industries AG est couverte par 31 analystes. 13 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Anil ShenoyBarclays
Andreas HeineBarclays
Sebastian BrayBerenberg